INSP Stock Recent News
INSP LATEST HEADLINES
The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.10 per share a year ago.
Inspire Medical Systems, Inc. (INSP) Q4 2023 Earnings Call Transcript
Inspire Medical's (INSP) revenue growth in the fourth quarter is likely to have been boosted by improved operating leverage.
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inspire Medical Systems, Inc. shares have dropped below their late 2020 levels despite a five-fold increase in sales. The company has seen impressive revenue growth, although coming down a bit amidst the law of large numbers. Although operating losses have decreased, more work is needed to improve profit margins and demonstrate operating leverage.
Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the third quarter.
Inspire Medical Systems, Inc. (NYSE:INSP ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President and Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Danielle Antalffy - UBS Securities LLC Robert Marcus - JPMorgan Chase & Co. Lei Huang - Wells Fargo & Company Travis Steed - Bank of America Jonathan Block - Stifel Financial Corp. Richard Newitter - Truist Securities Adam Maeder - Piper Sandler Companies Chris Pasquale - Nephron Research LLC David Rescott - Robert W. Baird & Co. Anthony Petrone - Mizuho Securities USA Mike Kratky - Leerink Partners LLC Mike Polark - Wolfe Research, LLC Suraj Kalia - Oppenheimer & Co. Inc. Operator Good afternoon.